Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Timing and cost of new vaccines vary by virus and health insurance status

Timing and cost of new vaccines vary by virus and health insurance status

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Only a small percentage of older adults with early Alzheimer's eligible for new treatments

Only a small percentage of older adults with early Alzheimer's eligible for new treatments

Most infants admitted to ICU for RSV were previously healthy, study finds

Most infants admitted to ICU for RSV were previously healthy, study finds

New Alzheimer’s drug raises hopes — along with questions

New Alzheimer’s drug raises hopes — along with questions

Immunotherapy after stem cell transplantation effectively combats certain childhood nerve tumors

Immunotherapy after stem cell transplantation effectively combats certain childhood nerve tumors

RSV vaccine recommendation rates increase when people are informed about FDA approval process

RSV vaccine recommendation rates increase when people are informed about FDA approval process

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

People living with HIV respond well to COVID-19 infection and vaccination

People living with HIV respond well to COVID-19 infection and vaccination

Cryo-EM structures and functions of potent bispecific antibodies against multiple Omicron sublineages

Cryo-EM structures and functions of potent bispecific antibodies against multiple Omicron sublineages

New treatment offers hope for children suffering from rare skin condition

New treatment offers hope for children suffering from rare skin condition

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

Monoclonal antibody shows promise in slowing progression of ALS

Monoclonal antibody shows promise in slowing progression of ALS

Experts weigh benefits and risks of new Alzheimer's disease therapies

Experts weigh benefits and risks of new Alzheimer's disease therapies

Tumor-derived GDF-15 suppresses immunotherapy response

Tumor-derived GDF-15 suppresses immunotherapy response

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

Donanemab shows promise in slowing Alzheimer's disease

Donanemab shows promise in slowing Alzheimer's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.